Survey of Patients Who Discontinued Botulinum Toxin A Injections for Spasmodic Dysphonia Robert W. Bastian, MD & James P. Thomas, MD Presented at the Western Section Triologic Society, San Francisco, CA 1/8/00
Blitzer A; Brin MF; Stewart CF. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 1998 Oct;108(10):1435-41.
Dedo HH; Behlau MS. Recurrent laryngeal nerve section for spastic dysphonia: 5- to 14-year preliminary results in the first 300 patients. Ann Otol Rhinol Laryngol 1991 Apr;100(4 Pt 1):274-9.
Berke GS; Blackwell KE; Gerratt BR; Verneil A; Jackson KS; Sercarz JA. Selective laryngeal adductor denervation-reinnervation: a new surgical treatment for adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 1999 Mar;108(3):227-31